TNL Mediagene Financials
This page shows TNL Mediagene (TNMG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth has not become self-funding scale; external financing is still filling the gap while short-term liquidity tightens.
From FY2023 to FY2024, revenue rose35.3% but operating cash outflow widened to-$10.2M , so added sales came with heavier cash demands rather than with cash-generating scale. Because financing inflow of$10.0M nearly matched that burn while net loss reached-$85.0M , FY2024 reads more like a liquidity bridge plus large non-cash earnings damage than a purely cash-driven deterioration.
The balance sheet looks like a liquidity constraint more than a leverage constraint: long-term debt was only
Accounting loss and cash burn diverged sharply in FY2024: goodwill fell from
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of TNL Mediagene's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
TNL Mediagene's revenue declined 26.1% year-over-year, from $48.5M to $35.8M. This contraction results in a growth score of 33/100.
TNL Mediagene carries a low D/E ratio of 0.11, meaning only $0.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
TNL Mediagene's current ratio of 0.54 is below the typical benchmark, resulting in a score of 5/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While TNL Mediagene generated -$1.4M in operating cash flow, capex of $87K consumed most of it, leaving -$1.5M in free cash flow. This results in a low score of 2/100, reflecting heavy capital investment rather than weak cash generation.
TNL Mediagene generates a -3.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -233.4% the prior year.
TNL Mediagene passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, TNL Mediagene generates $1.17 in operating cash flow (-$1.4M OCF vs -$1.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
TNL Mediagene generated $35.8M in revenue in fiscal year 2025. This represents a decrease of 26.1% from the prior year.
TNL Mediagene reported -$1.2M in net income in fiscal year 2025. This represents an increase of 98.6% from the prior year.
Cash & Balance Sheet
TNL Mediagene generated -$1.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 85.3% from the prior year.
TNL Mediagene held $3.6M in cash against $4.1M in long-term debt as of fiscal year 2025.
TNL Mediagene had 3M shares outstanding in fiscal year 2025. This represents a decrease of 90.2% from the prior year.
Margins & Returns
TNL Mediagene's net profit margin was -3.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 171.8 percentage points from the prior year.
TNL Mediagene's ROE was -3.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 230.1 percentage points from the prior year.
Capital Allocation
TNL Mediagene invested $87K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 2.2% from the prior year.
TNMG Income Statement
| Metric | Q3'25 | Q3'24 |
|---|---|---|
| Revenue | N/A | N/A |
| Cost of Revenue | N/A | N/A |
| Gross Profit | N/A | N/A |
| R&D Expenses | N/A | N/A |
| SG&A Expenses | N/A | N/A |
| Operating Income | N/A | N/A |
| Interest Expense | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income | N/A | N/A |
| EPS (Diluted) | N/A | N/A |
TNMG Balance Sheet
| Metric | Q3'25 | Q3'24 |
|---|---|---|
| Total Assets | $92.9M-22.3% | $119.6M |
| Current Assets | $17.7M+5.2% | $16.9M |
| Cash & Equivalents | $3.6M+20.3% | $3.0M |
| Inventory | $88K-24.0% | $116K |
| Accounts Receivable | $8.2M-6.9% | $8.8M |
| Goodwill | $34.0M-44.1% | $60.7M |
| Total Liabilities | $56.5M+19.6% | $47.2M |
| Current Liabilities | $33.0M+32.5% | $24.9M |
| Long-Term Debt | $4.1M-18.0% | $5.0M |
| Total Equity | $36.4M-49.7% | $72.4M |
| Retained Earnings | -$117.2M-264.0% | -$32.2M |
TNMG Cash Flow Statement
| Metric | Q3'25 | Q3'24 |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Investing Cash Flow | N/A | N/A |
| Financing Cash Flow | N/A | N/A |
| Dividends Paid | N/A | N/A |
| Share Buybacks | N/A | N/A |
TNMG Financial Ratios
| Metric | Q3'25 | Q3'24 |
|---|---|---|
| Gross Margin | N/A | N/A |
| Operating Margin | N/A | N/A |
| Net Margin | N/A | N/A |
| Return on Equity | N/A | N/A |
| Return on Assets | N/A | N/A |
| Current Ratio | 0.54-0.1 | 0.68 |
| Debt-to-Equity | 0.11+0.0 | 0.07 |
| FCF Margin | N/A | N/A |
Note: The current ratio is below 1.0 (0.54), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is TNL Mediagene's annual revenue?
TNL Mediagene (TNMG) reported $35.8M in total revenue for fiscal year 2025. This represents a -26.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is TNL Mediagene's revenue growing?
TNL Mediagene (TNMG) revenue declined by 26.1% year-over-year, from $48.5M to $35.8M in fiscal year 2025.
Is TNL Mediagene profitable?
No, TNL Mediagene (TNMG) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -3.4%.
How much debt does TNL Mediagene have?
As of fiscal year 2025, TNL Mediagene (TNMG) had $3.6M in cash and equivalents against $4.1M in long-term debt.
What is TNL Mediagene's net profit margin?
TNL Mediagene (TNMG) had a net profit margin of -3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is TNL Mediagene's return on equity (ROE)?
TNL Mediagene (TNMG) has a return on equity of -3.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is TNL Mediagene's free cash flow?
TNL Mediagene (TNMG) generated -$1.5M in free cash flow during fiscal year 2025. This represents a 85.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is TNL Mediagene's operating cash flow?
TNL Mediagene (TNMG) generated -$1.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are TNL Mediagene's total assets?
TNL Mediagene (TNMG) had $92.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are TNL Mediagene's capital expenditures?
TNL Mediagene (TNMG) invested $87K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is TNL Mediagene's current ratio?
TNL Mediagene (TNMG) had a current ratio of 0.54 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is TNL Mediagene's debt-to-equity ratio?
TNL Mediagene (TNMG) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is TNL Mediagene's return on assets (ROA)?
TNL Mediagene (TNMG) had a return on assets of -1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is TNL Mediagene's cash runway?
Based on fiscal year 2025 data, TNL Mediagene (TNMG) had $3.6M in cash against an annual operating cash burn of $1.4M. This gives an estimated cash runway of approximately 31 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is TNL Mediagene's Piotroski F-Score?
TNL Mediagene (TNMG) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are TNL Mediagene's earnings high quality?
TNL Mediagene (TNMG) has an earnings quality ratio of 1.17x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is TNL Mediagene?
TNL Mediagene (TNMG) scores 23 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.